GeoVax Labs GOVX
NASDAQ GOVX
$0.23 +0.01 (+2.25%)
At close: Oct 21, 2026 · 4:00 PM EDT

GeoVax Labs (GOVX) EPS (Basic) (2010 - 2026)

Updated

GeoVax Labs (GOVX) recorded EPS (Basic) of -$0.97 in Q2 2026, compared with -$0.35 a year earlier.

Analysis

GeoVax Labs (GOVX) EPS (Basic) (2010 - 2026) Analysis & Trends

On a TTM basis, GeoVax Labs' EPS (Basic) came in at -$4.50 as of Jun 30, 2026; for FY2025, it was -$22.40.

  • Across earlier years, EPS (Basic) came in at -$4.82 in FY2024, -$14.29 in FY2023, -$12.39 in FY2022 and -$45.66 in FY2021.
  • Quarterly EPS (Basic) has ranged from -$33.79 in Q4 2021 to -$0.31 in Q3 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.95
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 2.30
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.04
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -0.54
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.68
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.62
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -8.44
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -0.04
10 GeoVax Labs 1.04 Mn -13.29 Mn - -0.97
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.97
Dec 31, 2025 -4.61
Sep 30, 2025 -0.31
Jun 30, 2025 -0.35
Mar 31, 2025 -0.45
Dec 31, 2024 -1.59
Sep 30, 2024 -0.91
Jun 30, 2024 -1.99
Mar 31, 2024 -2.47
Dec 31, 2023 -4.18
Sep 30, 2023 -4.75
Jun 30, 2023 -3.36
Mar 31, 2023 -2.30
Dec 31, 2022 -4.76
Sep 30, 2022 -2.54
Jun 30, 2022 -2.64
Mar 31, 2022 -5.12
Dec 31, 2021 -33.79
Sep 30, 2021 -4.61
Jun 30, 2021 -3.12
API Access

GeoVax Labs EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=GOVX&period=max&api_key=YOUR_API_KEY